x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Category: Clinical Trials

    Marksman Healthcare > Blog > Clinical Trials

06May

The Role of Real World Evidence in Optimizing the Conduct of Clinical Trials

by MarksMan Healthcare,  0 Comments

Real-world evidence (RWE) is derived from real-world data (RWD) sources, such as electronic health records (EHRs), claims data, data from product/disease registries, pharmacy data, social media, and pragmatic trials. RWE […]

Read More

13Dec

The Evolving Role of Medical Affairs Professionals
in Clinical Trials

by MarksMan Healthcare,  0 Comments

The role of the medical affairs (MA) professional is constantly evolving, thanks to ever-increasing advancements and broadening scope of work in the pharmaceutical and healthcare domain. Of late, MA professionals […]

Read More

06Dec

Importance of Searching Clinical Trial Registries for Systematic Reviews

by MarksMan Healthcare,  0 Comments

Results from over half of all conducted randomized controlled trials (RCTs), especially those with negative or unfavorable results, never get published. This means, searching only electronic databases that index published […]

Read More

04Oct

How Real World Data (RWD) can Support Conducting Smarter Clinical Trials

by MarksMan Healthcare,  0 Comments

In a data-driven world, where everything can be digitalized, drug regulators and sponsors are increasingly looking beyond the confines of clinical trials. The use of real-world data (RWD) is becoming […]

Read More

13Mar

Impact of Information From ClinicalTrials.gov in the Conduct of SLRs?

by MarksMan Healthcare,  0 Comments

Systematic literature reviews (SLRs) are classically conducted with an aim of mapping the complete evidence base of a particular healthcare intervention, which enables an impartial evaluation of the evidence and […]

Read More

29Dec

How Important is to Maintain Clinical Trial Transparency?

by MarksMan Healthcare,  0 Comments

Clinical trials lay the foundation for the biomedical research enterprise. They not only assess the applicability of innovative laboratory findings in humans, but also generate robust evidence on treatments and/or […]

Read More

24Oct

How RWE can Impact Clinical Trial Design and Help in Decision Making?

by MarksMan Healthcare,  0 Comments

Real-world evidence (RWE) research is gaining significant importance in biopharmaceutical product development as well as its commercialization. The increasing need of the industry to seek broader information about the safety […]

Read More

06May

What are the Strategies for Effective Retention in Clinical Trials?

by MarksMan Healthcare,  0 Comments

The most recent evidence shows patient recruitment and retention issues to be a persistent problem in clinical trials. Also, it is almost certain that this problem will only continue to […]

Read More

14Sep

How Strong is the Evidence for Drugs Receiving FDA Accelerated Approval?

by MarksMan Healthcare,  0 Comments

A recently published study by Dyer O (2017) exposed major drawbacks in the accelerated approval process of some drugs available to the American patients without any stringent clinical evidence of […]

Read More

Posts navigation

1 2

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Patient Preference Information (PPI) in Healthcare:  What is it, and How is it Collected?

October 4, 2023

Automation in Evidence Synthesis: Are We There Yet?

September 28, 2023

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

Patient Preference Information (PPI) in Healthcare:  What is it, and How is it Collected?

October 4, 2023

Automation in Evidence Synthesis: Are We There Yet?

September 28, 2023

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...